Anticoagulation for people receiving long-term haemodialysis

Author:

Natale Patrizia123,Palmer Suetonia C4,Ruospo Marinella3,Longmuir Henrietta5,Dodds Benjamin5,Prasad Ritam6,Batt Tracey J7,Jose Matthew D5,Strippoli Giovanni FM138

Affiliation:

1. Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J); University of Bari Aldo Moro; Bari Italy

2. Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences; Universityof Foggia; Foggia Italy

3. Sydney School of Public Health; The University of Sydney; Sydney Australia

4. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

5. School of Medicine; University of Tasmania; Hobart Australia

6. Department of Haematology/Pathology; Royal Hobart Hospital; Hobart Australia

7. Department of Haematology; Westmead Hospital; Westmead Australia

8. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference304 articles.

1. Multicenter, prospective, randomized, crossover trial to demonstrate the benefits of hemodialysis without acetate (with citrate): ABC-treat study [abstract no: SA-PO789];De Sequera;Journal of the American Society of Nephrology,2017

2. Prospective randomised multicentre study to demonstrate the benefits of haemodialysis without acetate (with citrate): ABC-treat Study. Acute effect of citrate;Sequera Ortiz;Nefrologia,2019

3. Multicenter, prospective, randomised, crossover trial to demonstrate the benefits of hemodialysis without acetate (with citrate): ABC-TREAT study [abstract no: FP457];Sequera;Nephrology Dialysis Transplantation,2018

4. Advantages of the use of citrate over acetate as a stabilizer in hemodialysis fluid: A randomized ABC-treat study;Sequera;Nefrologia,2022

5. Augmentation of platelet reactivity by unfractionated heparin compared with enoxaparin in patients undergoing hemodialysis [abstract no: SA-PO1067];Aggarwal;Journal of the American Society of Nephrology,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3